NCT00935090
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
Clinical trial condition
Leukemia, T-Cell
Explore clinical trials studying Leukemia, T-Cell. Study availability and eligibility vary by location and protocol.
144 public trials
25 recruiting studies
Leukemia, T-Cell trial results
Recruiting
National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia
NCT07019766
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Red Blood Cell Diseases Center and Regenerative Medicine Center Tianjin, Tianjin Municipality, China
NCT05863234
- Conditions
- Aggressive NK Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Hiroshima University Hospital Hiroshima, Japan
Recruiting
Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies
NCT06909474
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China
NCT04014374
- Conditions
- ATLL, Cutaneous T Cell Lymphoma, Hematologic Diseases, +16 more
- Locations
-
- CIBMTR Milwaukee, Wisconsin, United States
Not Yet Recruiting
Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases
NCT07727083
- Conditions
- Aggressive NK-cell Leukemia, DNA Virus Infections, Epstein-Barr Virus Infections, +24 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Not Yet Recruiting
A Clinical Study on the Efficacy and Safety of Zeprumetostat in Relapsed/Refractory Large Granular Lymphocyte Leukemia
NCT07692529
- Conditions
- Evaluation of the Efficacy and Safety of Zeprumetostat in Relapsed/Refractory Large Granular Lymphocyte Leukemia (T-LGLL), Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
Not specified
Not Yet Recruiting
Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia
NCT07682792
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT05532722
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- City of Hope Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT01231412
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
- Locations
-
- University of Colorado Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States